Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101929084 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLIC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MAP3K3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FDX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF2AK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3R3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MASP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OVCA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHKB-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPAR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABI3BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM50B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERTAD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on